Short description
HTG Molecular Diagnostics develops assays and reagent systems for gene expression analysis.
Description
HTG Molecular Diagnostics is a provider of molecular-based technology solutions for gene expression profiling, miRNA, siRNA and mRNA measurement for translational medicine and diagnostic applications.
The Company's NGS-adapted chemistry and HTG EdgeSeq technology automate sample processing and can swiftly, reliably, and concurrently profile hundreds or thousands of molecular targets utilizing a very little quantity of biological material, in liquid or solid form. Its products comprise equipment, consumables, and software that work together to form the HTG EdgeSeq platform. The HTG EdgeSeq platform automates the company's menu of HTG EdgeSeq molecular profiling panels, which use genomic sequencing techniques to swiftly provide gene expression data for clients utilizing its streamlined approach.
HTG Molecular Diagnostics was established in 1997 by Bruce E. Seligmann in Tucson, Arizona.
Last funding
Noaccessforu
Sign in for full access
Total funding
$$2020202
Sign in for full access
Location
Tucson, Arizona, United States, North America
Founded on
January 1, 1997
Exited on
April 28, 2015
Went public on
April 28, 2015
Stock symbol
HTGM
Non-profit?
No
Acquired?
No
Employees count
51-100
Revenue range
$34056 - 789030
Sign in for full access
Investors
Blurry Noaccess, Uh Ohhhh, Noaccess, Cannot Access, Absolutely Noaccess, Noaccess, Noaccess, Noaccess, Nopepepe, Noway Youcantaccess, Cannot Access
Sign in for full access
Founders
Bruce E. Seligmann